Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1999 (Third Quarter of Fiscal Year 1999)
Business Overview: The company manufactures and distributes herbal and nutritional products through multi-level and retail distribution channels. The reporting period reflects a significant downturn in market demand for herbal products, leading to inventory liquidations and strategic restructuring.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 1999 |
Nine Months Ended Mar 31, 1999 |
Nine Months Ended Mar 31, 1998 |
|---|---|---|---|
| Net Sales | $13,122,768 | $47,425,699 | $47,290,172 |
| Gross Profit | $1,890,817 | $9,810,345 | $12,827,165 |
| Gross Margin % | 14.4% | 20.7% | 27.1% |
| Operating Income (Loss) | ($7,252,661) | ($4,148,002) | $6,188,255 |
| Net Earnings (Loss) | ($4,320,762) | ($2,418,362) | $3,785,172 |
| Diluted EPS | ($0.73) | ($0.41) | $0.66 |
| Cash from Operations | N/A | $217,285 | $1,440,756 |
| Cash & Equivalents | $2,683,394 | $2,683,394 | $3,399,360 |
| Working Capital | $15,475,164 | $15,475,164 | N/A |
| Total Debt (Current + Long-term) | $989,330 | $989,330 | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales for the quarter dropped 30.8% ($5.8 million) compared to the prior year quarter, driven by weakened demand for herbal products. However, nine-month sales remained relatively flat compared to the prior year.
- Margin Compression: Gross margins fell from 27.5% to 14.4% in the quarter due to depressed market prices, inventory write-downs, and the liquidation of slow-moving items at or below cost.
- Operating Loss: The company swung from an operating income of $3.0 million in the prior year quarter to an operating loss of $7.3 million. This was primarily caused by a $5.6 million charge in Selling, General & Administrative (SG&A) expenses.
- SG&A Charges: The $5.6 million charge included approximately $5.0 million for costs related to subleasing a proposed new facility in Carlsbad, California, and $0.6 million for severance expenses due to management restructuring.
- Balance Sheet: Total assets decreased by approximately $9.1 million year-over-year, largely due to reductions in accounts receivable and inventory levels.
Guidance, Outlook, and Risks
- Capital Expenditures: The company anticipates capital expenditures of approximately $6.0 million for fiscal 1999, funded by cash holdings, operating cash flow, and potential debt or equity financing.
- Liquidity: The company maintains $3.0 million in available revolving lines of credit with no current borrowings. Management expects to renew these lines upon expiration in January 2000.
- Year 2000 Compliance: The company estimates $1 million in total costs to resolve Year 2000 issues, with $100,000 charged to expense. Remediation is expected to be fully implemented by the end of the first quarter of fiscal 2000.
- Customer Concentration: Three customers accounted for 72% of sales in the quarter and 73% for the nine-month period. The loss of any of these customers could materially impact revenues.
- Forward-Looking Risks: Risks include the inability of suppliers to be Year 2000 compliant, potential inability to secure financing for capital projects, and continued market demand weakness.
Investor Verification Checklist
- Facility Sublease: Verify the status of the Carlsbad facility sublease and the accuracy of the $5.0 million charge.
- Inventory Valuation: Confirm the extent of inventory write-downs and the remaining value of slow-moving herbal product inventory.
- Customer Retention: Assess the stability of the top three customers who represent over 70% of revenue.
- Financing Availability: Monitor the renewal status of the $3.0 million line of credit expiring in January 2000.
- Year 2000 Costs: Track actual Year 2000 remediation costs against the $1 million estimate to ensure no material overruns.